Characteristics | Normal group (n = 33) | Non-significant stenosis group (n = 33) | Significant stenosis group (n = 33) | P value |
---|---|---|---|---|
Age | 53.12 ± 8.33 | 55.73 ± 6.80 | 56.82 ± 9.41 | 0.297 |
Gender (Male, n, %) | 14(42.42) | 21(63.64) | 24(72.73) | 0.326 |
BMI | 23.78 ± 4.35 | 25.44 ± 5.12 | 25.43 ± 6.43 | 0.124 |
Hypertension (n, %) | 17 (51.52) | 21 (63.64) | 22 (66.67) | 0.215 |
Diabetes (n, %) | 9 (27.27) | 13 (39.39) | 15 (45.45) | 0.413 |
Smoking (n, %) | 11(33.33) | 18 (54.55) | 17 (51.52) | 0.158 |
Family history of CHD (n, %) | 8(24.24) | 9(27.27) | 13(39.39) | 0.594 |
HDL cholesterol | 1.05 ± 0.87 | 0.99 ± 0.76 | 0.92 ± 0.81 | 0.252 |
LDL cholesterol | 2.54 ± 0.67 | 2.91 ± 0.83 | 3.26 ± 0.78 | 0.127 |
Total cholesterol | 4.18 ± 0.48 | 4.59 ± 0.62 | 4.91 ± 0.43 | 0.234 |
Triglyceride | 1.62 ± 0.32 | 2.08 ± 0.48 | 2.45 ± 0.51 | 0.211 |
Medicine | ||||
Aspirin | 31(93.94) | 33(100) | 33(100) | 0.761 |
Statins | 22(66.67) | 31(93.94) | 33(100) | 0.436 |
The narrowest lesion location | ||||
LAD (n, %) | 24(72.73) | 28(84.85) | ||
RCA (n, %) | 7(21.21) | 4(12.12) | ||
LCX (n, %) | 1(3.03) | 1(3.03) | ||
LM (n, %) | 1(3.03) | 0(0) | ||
The narrowest lesion plaque | ||||
Non-calcified | 8(24.24) | 9(27.20) | ||
Calcified plaque | 11(33.33) | 4(12.10) | ||
Mixed | 14(42.40) | 20(60.60) |